We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App





Lab-in-a-Backpack Offers Fast, Affordable, Reliable COVID-19 Testing

By LabMedica International staff writers
Posted on 28 Jan 2022

Researchers have created a simple COVID-19 testing lab that fits into a backpack providing a cheap and effective solution for low income or remote areas. More...

In a new study, scientists from Queen Mary University of London (London, UK) have shown that their lab-in-a-backpack approach is as effective as commercially available COVID-19 tests at detecting SARS-CoV-2. The compact kit is relatively inexpensive to make, costing USD 51 in total. It could offer an alternative testing solution for resource-poor countries or remote areas with little access to well-equipped testing labs or trained personnel to process samples. The testing kit is based on a simple, non-invasive COVID-19 LAMP test and uses low-cost hardware, including a centrifuge made from recycled computer hard drives, called a CentriDrive, to process samples.

The LAMP test is a widely accepted alternative to the commonly used PCR test, has a similar sensitivity but unlike the PCR test does not require temperature cycling, only a single high temperature to amplify any potential virus RNA. This allows the test to be performed with only minimal equipment and reagents. Because the LAMP test uses saliva samples, it also avoids the need for invasive, uncomfortable nasal swabs. However, the high costs of commercially available LAMP tests, as well as the expensive lab equipment required to run them, means that current commercial approaches aren’t suitable for remote locations, or in-home testing.

According to the researchers, the next steps will include making the kit instructions even more understandable so that people can use them regardless of their experience or language, as well as validating the kit with real patient samples. So, whilst this approach holds promise, further work is needed before the system can be implemented in real-world environments.

“In this study, using the LAMP test method in combination with a low-cost centrifuge, we provided an inexpensive, rapid and accurate method for the detection of COVID-19,” said Emily Lin, lead author of the study. “It will not only provide a viable and inexpensive test kit for regions such as Africa, where innovative solutions are particularly important during the Covid-19 pandemic. It can also be used in resource-rich areas, for example, in high school classrooms to demonstrate how to test for COVID-19.”

“We are excited for the potential of this mobile lab to do COVID-19 tests and the possibility to democratize access to inexpensive testing technology,” said Professor Stoyan Smoukov, Professor of Chemical Engineering at Queen Mary University of London. “It is made possible by our philosophy of creating low-cost instruments whenever possible from advances in electronics, or existing instruments.”

“Reuse is a high-value option for energy and materials sustainability, and we are glad that rather than exporting electronics waste to developing countries, we can export ways to empower people and turn waste computer hard drives into a centrifuge. The COVID-19 test is a timely application, but we also believe with this CentriDrive kit people could perform a large array of routine blood and urine tests, providing a centrifuge away from central hospital facilities,” added Professor Smoukov.

Related Links:
Queen Mary University of London 


Platinum Member
Fully Automatic ACLIA Analyzer
MAGLUMI X8
Gold Member
Universal Transport Solution
Puritan®UniTranz-RT
New
Gold Member
Serum Indices Control
Acusera Serum Indices Control
New
Portable POCT Blood Gas Analyzer
BD100
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image Credit: Shutterstock

Blood Test Could Guide Drug Selection to Prevent Repeat Heart Attacks and Strokes

Secondary prevention after myocardial infarction or stroke relies on antiplatelet therapy, yet responses vary widely and both recurrent thrombosis and bleeding remain persistent risks. In the United Kingdom,... Read more

Molecular Diagnostics

view channel
Image: MPNST is a cancer of the connective tissue surrounding peripheral nerves, with NF1 being a key risk factor (Image Credit: Nephron/Wikimedia Commons (CC BY-SA 3.0)

Liquid Biopsy Shows Promise for Detecting and Monitoring Malignant Nerve Sheath Tumors

Malignant peripheral nerve sheath tumor (MPNST) is one of the most serious cancers affecting people with neurofibromatosis type 1 (NF1), yet timely recognition remains difficult. Clinicians often struggle... Read more

Immunology

view channel
Image: Although many people harbor latent Epstein-Barr virus (EBV), growing evidence has linked the virus to MS pathobiology (Image Credit: Adobe Stock)

Blood EBV Activity Biomarkers May Predict Multiple Sclerosis Relapse Months Ahead

Predicting relapse in multiple sclerosis (MS) remains difficult, limiting opportunities for timely intervention and monitoring. Although many people harbor latent Epstein-Barr virus (EBV), growing evidence... Read more

Microbiology

view channel
Image: Type 1 diabetes affects more than 9 million people worldwide and can begin years before symptoms appear, making early identification of at-risk children difficult (Image Credit: iStock)

Early-Life Gut Microbiome Changes May Help Assess Type 1 Diabetes Risk

Type 1 diabetes (T1D) affects more than 9 million people worldwide, including 1.8 million children and adolescents, and often begins years before symptoms appear. Early identification of children who are... Read more

Pathology

view channel
Image: A new study demonstrates that vascular features in colorectal tumors could serve as prognostic biomarkers of disease outcome. (Image Credit: iStock)

Tumor Blood Vessel Features May Help Predict Colorectal Cancer Survival

Colorectal cancer outcomes vary widely, and tumor biology remains a key determinant of prognosis. Because neoplasms depend on a vascular supply, differences in intratumoral vessels may influence survival.... Read more

Technology

view channel
Image: ADLM recommends that emerging AI tools follow the same professional oversight, quality, validation, and monitoring standards as traditional clinical testing within CLIA’s existing framework (Image Credit: Adobe Stock)

ADLM Calls for CLIA Updates to Support Safe AI Use in Laboratory Medicine

Clinical laboratories increasingly use artificial intelligence to verify, interpret, and report results, but safeguards under the Clinical Laboratory Improvement Amendments (CLIA) were designed in 1992.... Read more

Industry

view channel
Image: Central to the collaboration is the Enhanced Liver Fibrosis (ELF) test, a noninvasive blood test authorized in the U.S. to assess disease progression risk in patients with advanced fibrosis due to MASH and support patient management decisions. (Photo courtesy of Siemens Healthineers)

Siemens Healthineers and Novo Collaborate to Expand Access to Noninvasive Liver Testing

Metabolic dysfunction‑associated steatotic liver disease (MASLD) and its progressive form, metabolic dysfunction‑associated steatohepatitis (MASH), affect millions and are linked to obesity, type 2 diabetes,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.